Ophthalmic Consultants of Boston Inc (OCB) — Boston, Massachusetts

Ophthalmic Consultants of Boston Inc (OCB) is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.

Ophthalmic Consultants of Boston Inc (OCB) has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Solid Tumors Harboring a BRAF V600 Mutation, Malignant Melanoma, Carcinoma, Non-Small-Cell Lung.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ophthalmic Consultants of Boston Inc (OCB)?

Ophthalmic Consultants of Boston Inc (OCB) has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ophthalmic Consultants of Boston Inc (OCB) conducted?

Ophthalmic Consultants of Boston Inc (OCB) has 5 clinical trials on record, with 2 currently active. Their work covers Solid Tumors Harboring a BRAF V600 Mutation, Malignant Melanoma, Carcinoma, Non-Small-Cell Lung.

Is Ophthalmic Consultants of Boston Inc (OCB) accredited by Crixeo Health?

Ophthalmic Consultants of Boston Inc (OCB) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ophthalmic Consultants of Boston Inc (OCB)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.